The laboratory of Dr. Michael Green is focused on understanding the molecular etiology of B-cell lymphoma, and aims to use this knowledge to identify novel therapeutic strategies. Our laboratory employs high-throughput genomics to interrogate primary tumor specimens and transgenic mouse models; including whole-genome/exome sequencing, RNA-seq, ChIP-seq, CUT&RUN and ATAC-seq, as well as cutting-edge single cell approaches. This position will focus on the integration and analysis of single cell RNA-sequencing and spatial transcriptomics datasets from lymphoma patient's, as a progression and expansion of our recent work. **LEARNING OBJECTIVES** Trainee will participate in developing and evaluating novel adoptive T-cell therapy strategies including CAR-T and TCR-T, and viral- and tumor antigen-specific T cells in both in vitro and in vivo models. Trainee will work in a high-performance computing cluster environment. Trainee will work with single cell RNA/ATAC, ChIP-seq, ATAC-seq, and Hi-C. **ELIGIBILITY REQUIREMENTS** Individuals with a PhD degree in computational biology, bioinformatics, genomics, genome science or a related field are encouraged to apply. A strong computational background, proficiency in at least one programming language (e.g., R, Python, Perl, C++, Java) and knowledge of biostatistics are required. **ADDITIONAL APPLICATION INFORMATION** n/a **POSITION INFORMATION** MD Anderson offers full-time postdoc positions with a salary ranging from $64,000 to $76,000 (https://trainees.mdanderson.org/apply/mdaPostdoctoralFellowStipendFY24.pdf) . depending on the number of years of postgraduate experience. The University of Texas MD Anderson Cancer Center offers excellent benefits (https://www.utsystem.edu/offices/employee-benefits/insurance-0/eligibility) , including medical, dental, paid time off (https://www.mdanderson.org/about-md-anderson/employee-resources/leave.html) , retirement (https://www.utsystem.edu/offices/employee-benefits/ut-retirement-program/voluntary-retirement-programs) , tuition benefits, educational opportunities, and individual and team recognition02/28/2025